MAPT and brain ischemia: Among these, tau proteins, a microtubule associated protein, and the corresponding hyperphosphorylated forms, p-tau, are well-established biomarkers of neurodegeneration, and represent predictors of functional outcome (61) or development of cognitive dysfunction after cerebral ischemia (62–64).